Coherus Oncology (CHRS) Cash from Investing Activities (QoQ) (2014 - 2026)
Coherus Oncology (CHRS) Cash from Investing Activities (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Coherus Oncology | 194.37 Mn | 27.32 Mn | 8.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,180.16% |
| Dec 31, 2025 | 95.78% |
| Sep 30, 2025 | -114.53% |
| Jun 30, 2025 | 2,745.76% |
| Mar 31, 2025 | -3,126.20% |
| Dec 31, 2024 | -222.07% |
| Sep 30, 2024 | -98.39% |
| Jun 30, 2024 | -86.36% |
| Mar 31, 2024 | 475.98% |
| Dec 31, 2023 | -30.35% |
| Sep 30, 2023 | 22.20% |
| Jun 30, 2023 | 136.02% |
| Mar 31, 2023 | 113.49% |
| Dec 31, 2022 | -28,324.07% |
| Sep 30, 2022 | 48.07% |
| Jun 30, 2022 | 97.53% |
| Mar 31, 2022 | -133.13% |
| Dec 31, 2021 | 572.23% |
| Sep 30, 2021 | -32.20% |
| Jun 30, 2021 | 108.26% |